![Cord Dohrmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cord Dohrmann
Directeur Général chez
Evotec International GmbH
Fortune : 720 492 $ au 31/08/2026
Profil
Dr. Cord E.
Dohrmann is a Co-Managing Director at Evotec International GmbH and a Member at German Council of Science & Humanities.
He is on the Board of Directors at FSHD Unlimited Cooperatie Ua, Breakpoint Therapeutics GmbH, Eternygen GmbH and Facio Therapies.
Dr. Dohrmann was previously employed as a Chief Scientific Officer by Evotec SE, a Chief Executive Officer by DeveloGen AG, a Principal by Duke University, a Principal by Eberhard Karls Universität Tübingen, and a Principal by The General Hospital Corp.
He received his undergraduate degree from Eberhard Karls Universität Tübingen, a graduate degree from the Max-Planck-Institute for Molecular Genetics and a doctorate degree from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOTEC SE 0,11 % | 31/12/2025 | 191 084 ( 0,11 % ) | 720 492 $ | 31/08/2026 |
Postes actifs de Cord Dohrmann
| Sociétés | Poste | Début |
|---|---|---|
Eternygen GmbH
 Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs | Directeur/Membre du Conseil | - |
FSHD Unlimited Cooperatie Ua
 FSHD Unlimited Cooperatie Ua Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company with a focus on facioscapulohumeral dystrophy | Directeur/Membre du Conseil | 01/06/2017 |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Directeur Général | - |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Directeur/Membre du Conseil | - |
Facio Therapies
 Facio Therapies Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | - |
German Council of Science & Humanities | Corporate Officer/Principal | - |
Anciens postes connus de Cord Dohrmann
| Sociétés | Poste | Fin |
|---|---|---|
| EVOTEC SE | Directeur Technique/Scientifique/R&D | Aujourd'hui |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Directeur Général | 25/01/2012 |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Cord Dohrmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
DeveloGen AG
DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Health Technology |
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eternygen GmbH
Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs | Health Technology |
German Council of Science & Humanities | |
FSHD Unlimited Cooperatie Ua
FSHD Unlimited Cooperatie Ua Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company with a focus on facioscapulohumeral dystrophy | Health Technology |
Facio Therapies
Facio Therapies Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Health Technology |
